XuanYu Medical Exhibits
(Image source: CSITF)
In the field of medical devices,Xuanyu MedicalShowcasing a range of innovative products at this year’s Shanghai International Technology Fair,Including the SHINERHYTHM® Cardiac Pulsed Field Ablation System and the RHYTHPULSE® Disposable Cardiac Pulsed Field Ablation Catheter. Notably,Not long ago, XuanYu Medical’s “Adjustable-Curve Pulmonary Artery Embolectomy Stent System” received market approval. This marks the 10th Class III innovative medical device from Zhangjiang Pharma Valley to be approved this year.
(Image source: NeuroXess)
NeuracleIt showcased its self-developed invasive brain-computer interface (BCI) system for compensating hand motor function, NEO. As the world’s first approved and marketed invasive BCI product, it assists patients with spinal cord injury in restoring hand grasping function.
In March 2026, NEO received NMPA approval for market launch, becoming the world’s first approved invasive brain-computer interface medical device.
Aoyi Technology Exhibits
(Image source: Pudong Sci-Tech Innovation Group)
Aoyi TechnologyThe exhibition area also attracted significant attention. The company has deeply cultivated the fields of EEG and EMG signal acquisition, AI-based decoding of motor intent algorithms, and the development of multi-degree-of-freedom bionic robots. It has established four comprehensive technological systems: brain-computer interfaces, electromyographic sensing, rehabilitation robotics, and bionic dexterous hands. All proprietary technologies, including specialized neural interface chips, core algorithms, and terminal hardware, are fully independently controlled.
At the thematic forum held concurrently with the China (Shanghai) International Technology Fair, the Vice President of Oyi Technology systematically elaborated on the company’s development strategy to evolve from non-invasive technologies toward a brain-computer interface platform, continuously expanding the boundaries of human-computer interaction.
(Image source: Siyi Intelligence)
SiYi IntelligenceAlso unveiled at this CIIE is a core cutting-edge technology: a 32-channel brain-computer interface (BCI) robotic system for hand function rehabilitation. Leveraging high-precision 32-channel EEG acquisition technology, the device accurately captures users’ motor intentions, enabling intention-controlled hand movement and active rehabilitation. Through closed-loop BCI training, it helps patients with hand functional impairments due to stroke or traumatic brain injury to rewire neural pathways and regain voluntary hand mobility more rapidly.
Jingwei Likang Exhibits
(Image source: CSITF)
Jingwei LikangThis marks the company’s debut at the conference. “We globally launched the ‘Immune-Organoid Fully Closed-Loop Intelligent Drug Screening Super Workstation’ for the first time at the exhibition,” said Sun Yazhu, General Manager of Jingwei Likang. Leveraging its premiere at the Shanghai International Technology Fair, Jingwei Likang showcased five breakthrough technologies. These advancements include the establishment of standardized SOPs for tumor-immune co-culture systems, achieving over 85% uniformity in organoids, enabling more than 90% labor substitution through fully automated workstations, and the inaugural release of an AI-driven dual-cell intelligent recognition and interaction analysis algorithm.
This means that Jingwei Likang not only addresses the shortcomings of the domestic industry, but also achieves full-chain autonomous and controllable domestic substitution through complex organoid models + intelligent hardware + AI algorithms, resolving the industry's critical bottlenecks in one stroke.
